BioUtah News

KidneyIntelX Medicare Update

Renalytix announced that the Federal Medicare Administrative Contractor (MAC) National Government Services (NGS) has initiated payment of claims…
15th Annual 2022 Women Tech Award Recipients

The Women’s Tech Council announced eight award recipients from its twenty one finalists.
Geneial Receives $2.3M NIH Grant

Geneial announces a multimillion dollar, non-dilutive award from the National Human Genome Research Institute to fund the development…
SINTX TECHNOLOGIES AWARDED DEPARTMENT OF ENERGY GRANT FOR DEVELOPMENT OF 3D PRINTED CERAMIC HEAT EXCHANGERS

SINTX announces the receipt of a Phase II award of $1.1M, issued by the U.S. Department of Energy…
NATIONAL INSTITUTES OF HEALTH AWARDS GRANT TO SINTX TECHNOLOGIES FOR DEVELOPMENT OF 3D PRINTED ANTIMICROBIAL TRAUMA DEVICE

SINTX announced a Phase I grant of $275k awarded by the National Institutes of Health (NIH) to develop…
Brandy Isaacks Joins CenExel as Vice President of Project Management & Scientific Affairs

CNS Clinical Research Veteran Brings Extensive Expertise in Global Project Management & Operations
Foldax Appoints Gregory D. Casciaro as Chief Executive Officer

Foldax announced that medtech veteran Gregory D. Casciaro has been named Chief Executive Officer of the company, effective…
KidneyIntelX Clinical Utility and Health Economics Validated in Multiple Data Releases at American Society of Nephrology

Four presentations, including first clinical utility findings from multi-year real world evidence results from a major healthcare system…
EVŌQ Bio is Fielding Partnership Inquiries for its Antimicrobial Medical Materials Additives at the MedTech Conference

Attendance at premiere medical technology convention to spur partnership, growth opportunities. SALT LAKE CITY, October 10, 2022 /PRNewswire/…
Owlet Announces FDA 510(k) Submission for Prescription Pediatric Monitor

LEHI, Utah–(BUSINESS WIRE)– Owlet, Inc. (NYSE: OWLT) (the “Company”) announces that it has submitted a 510(k) premarket notification…
Phoenix PharmaLabs Awarded $8.7 Million Grant from NIDA to Study Compound for Treatment of Cocaine Use Disorder

Woods Cross, UT (October 6, 2022) – Phoenix PharmaLabs, Inc. (https://phoenixpharmalabs.com), a private company developing potent, non-addictive treatments…
Xenter, the World’s First “TechMed” Company, Unveils the XenFI Wireless Network

Xenter unveiled XenFI™, the first product in its wireless “Technology in Medicine” ecosystem.